Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results( )

BACKGROUND: OVX836 is a recombinant protein vaccine targeting the highly conserved influenza nucleoprotein (NP), which could confer broad-spectrum protection against this disease. METHODS: A randomized, placebo-controlled, double-blind, dose-escalating, single- center, first-in-human study was condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Withanage, Kanchanamala, De Coster, Ilse, Cools, Nathalie, Viviani, Simonetta, Tourneur, Jessika, Chevandier, Marion, Lambiel, Manon, Willems, Paul, Le Vert, Alexandre, Nicolas, Florence, Van Damme, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373130/
https://www.ncbi.nlm.nih.gov/pubmed/34653245
http://dx.doi.org/10.1093/infdis/jiab532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373130/
https://www.ncbi.nlm.nih.gov/pubmed/34653245
http://dx.doi.org/10.1093/infdis/jiab532

Ejemplares similares